Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

How to calculate the power of study / number of subjects in phase III (safety & efficacy) trial?

April 26, 2017CALCULATE III phase power safety study Subjects trial

0

Posted

How to calculate the power of study / number of subjects in phase III (safety & efficacy) trial?

1 Answer

0

Posted

BALA: We use primary efficacy endpoint to base our power calculation to compare placebo (or active control) versus the drug. The power computation will be done using noncentral t-distribution. Any standard biostatistics book would explain this in detail.